Patent 9687448 was granted and assigned to Alnylam Pharmaceuticals on June, 2017 by the United States Patent and Trademark Office.
The present invention relates to lipid nanoparticles containing a biodegradable cationic lipid which provide improved delivery of active pharmaceutical ingredients, such as siRNA.